1. Home
  2. FRO vs RARE Comparison

FRO vs RARE Comparison

Compare FRO & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRO
  • RARE
  • Stock Information
  • Founded
  • FRO 1985
  • RARE 2010
  • Country
  • FRO Cyprus
  • RARE United States
  • Employees
  • FRO N/A
  • RARE N/A
  • Industry
  • FRO Marine Transportation
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRO Consumer Discretionary
  • RARE Health Care
  • Exchange
  • FRO Nasdaq
  • RARE Nasdaq
  • Market Cap
  • FRO 3.6B
  • RARE 3.6B
  • IPO Year
  • FRO N/A
  • RARE 2014
  • Fundamental
  • Price
  • FRO $14.95
  • RARE $35.37
  • Analyst Decision
  • FRO Strong Buy
  • RARE Strong Buy
  • Analyst Count
  • FRO 3
  • RARE 15
  • Target Price
  • FRO $27.33
  • RARE $95.93
  • AVG Volume (30 Days)
  • FRO 2.8M
  • RARE 696.2K
  • Earning Date
  • FRO 02-28-2025
  • RARE 05-01-2025
  • Dividend Yield
  • FRO 11.95%
  • RARE N/A
  • EPS Growth
  • FRO N/A
  • RARE N/A
  • EPS
  • FRO 2.23
  • RARE N/A
  • Revenue
  • FRO $2,050,385,000.00
  • RARE $560,230,000.00
  • Revenue This Year
  • FRO N/A
  • RARE $19.15
  • Revenue Next Year
  • FRO $12.01
  • RARE $32.11
  • P/E Ratio
  • FRO $6.75
  • RARE N/A
  • Revenue Growth
  • FRO 13.77
  • RARE 29.01
  • 52 Week Low
  • FRO $13.17
  • RARE $33.53
  • 52 Week High
  • FRO $29.39
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • FRO 40.44
  • RARE 35.78
  • Support Level
  • FRO $14.28
  • RARE $36.71
  • Resistance Level
  • FRO $15.31
  • RARE $39.21
  • Average True Range (ATR)
  • FRO 0.46
  • RARE 1.40
  • MACD
  • FRO -0.09
  • RARE -0.33
  • Stochastic Oscillator
  • FRO 24.54
  • RARE 27.57

About FRO Frontline Plc

Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: